These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 447479)

  • 21. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):207-13. PubMed ID: 7414765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urinary citrate determination in normal persons and in patients with recurrent urinary calculi].
    Noronha Ide L; Andriolo A; Wroclawski E; Chade J; Lucon AM; Arap e Emil S; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):12-8. PubMed ID: 1307398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A correlation and path coefficient analysis of components of calciuria in normal subjects and idiopathic stone formers.
    Puche RC; Carlomagno AF; Gonzalez A; Sanchez A
    Bone Miner; 1987 Aug; 2(5):405-11. PubMed ID: 3505767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary ionic calcium and binding sites in normocalciuric idiopathic calcium urolithiasis.
    Jacobson AL; Singhal PC; Mandin H; Hyne JB
    Invest Urol; 1979 Nov; 17(3):218-22. PubMed ID: 500320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
    Normand M; Cayotte JL; Houillier P; Peuchant A; Paillard M
    Nephrologie; 1993; 14(6):283-5. PubMed ID: 8145886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indication of the urinary citrate levels in idiopathic renal calculosis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Mar; 116(12):371-3. PubMed ID: 3961456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary citrate excretion in stone-formers and normal controls.
    Welshman SG; McGeown MG
    Br J Urol; 1976 Feb; 48(1):7-11. PubMed ID: 1268467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
    Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
    [No Abstract]   [Full Text] [Related]  

  • 35. [Urinary magnesium and its relationship to calcium in recurrent stone-formers and controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):214-9. PubMed ID: 7414766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of inhibitor deficiency in urolithiasis. II. Deficiency grade-adjusted and intermittent augmentation therapy for magnesium and citrate deficiency.
    Esen T; Akinci M; Tellaloğlu S; Koçak T
    Eur Urol; 1991; 19(3):244-8. PubMed ID: 1855531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on citrate metabolism in normal subjects and kidney stone patients.
    Minisola S; Rossi W; Pacitti MT; Scarnecchia L; Bigi F; Carnevale V; Mazzuoli G
    Miner Electrolyte Metab; 1989; 15(5):303-8. PubMed ID: 2811789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.